Left Ventricular Recovery after Transapical Transcatheter Aortic Valve Implantation Compared with Conventional Aortic Valve Replacement in Patients with Aortic Regurgitation and Reduced Ejection Fraction
Table 1
Comparison of patients’ baseline demographic and clinical characteristics.
Variablesa
Total sample (n = 87)
Patient groups
value
TA-TAVR (n = 36)
SAVR (n = 51)
Age (yr)
68.0 (62.0–72.5)
73.0 (71.0–75.3)
64.0 (55.5–67.0)
<0.001
Male (n)
32
24
27
0.290
BMI (kg/m2)
21.65 (19.21–24.40)
22.24 (19.23–25.14)
21.48 (19.19–23.64)
0.278
Smoking history (n)
24
12
12
0.445
Diabetes (n)
13
8
5
0.195
Hypertension (n)
37
18
13
0.034
Peripheral vascular disease
6
3
3
0.657
NYHA class (n)
II
21
9
8
0.185
III
56
21
39
IV
10
6
4
AF (n)
13
7
6
0.494
Renal insufficiency (n)
8
5
3
0.203
Dialysis (n)
3
2
1
0.365
COPD (n)
9
5
2
0.092
Cancer history (n)
4
2
2
0.720
Lung cancer
2
1
Thyroid cancer
0
1
Stroke history (n)
28
5
4
0.952
CAD (n)
22
12
10
0.230
Prior MI (n)
5
3
2
0.383
Liver dysfunction (n)
8
5
3
0.203
Prior cardiac surgery (n)
5
2
3
0.949
LVEF (%)
43.70 (41.65–45.85)
43.35 (41.48–45.68)
44.40 (42.25–46.15)
0.278
LVEDD (mm)
70.70 (68.05–75.30)
69.95 (68.30–74.95)
70.80 (67.65–75.55)
0.945
BAV (n)
18
3
15
0.034
Additive Euroscore
6 (3–7)
7 (6–9)
4 (2–5.5)
<0.001
BMI, body mass index; NYHA, New York heart association; AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; MI, myocardial infarction; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic dimension; BAV, bicuspid aortic valve. aNon-normally distributed variables are presented as median (interquartile range (IQR)) and categorical data as numbers.
